Compare Reliance Sekuritas Indonesia Tbk. (RELI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reliance Sekuritas Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Reliance Sekuritas Indonesia Tbk. trades at Rp496 (market cap 874.8B, 398.1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 14.4× Reliance Sekuritas Indonesia Tbk.'s market cap, and Reliance Sekuritas Indonesia Tbk. is more actively traded (398.1K versus 235.2K). Which is the better fit depends on your goals.
| RELI | TSPC | |
|---|---|---|
Market Cap | 874.8B | 12.58T |
Volume | 398.1K | 235.2K |
Lot | 3.98K | 2.35K |
Turnover | 206.36M | 649.94M |
Average Price | 518.35 | 2,763.37 |
Value | 206.36M | 649.94M |
Indicative Equilibrium Price | 496 | 2,780 |
Indicative Equilibrium Volume | 15 | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Reliance Sekuritas Indonesia Tbk.
PT. Reliance Securities (the company) was established under its original name of Istethmar Finas Securities on 22 Feb 1993 then changed to PT Ludlow Securities on 13 Sep 1999. According with Notaries deed on 28 March 2003 company's name changed to PT Reliance Securities. And the company's name changed to PT Reliance Securities Tbk on 19 May 2005 with amended the articles of association no 19 dated 14 April 2005.
Read more on RELI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
